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Abstract
Purpose
Maslinic acid (MA) is a component derived from a natural olive-based extract known to have
pharmacological functions that include suppressing inflammation. This study examined how
MA, in conjunction with whole-body vibration training (WBVT), can improve knee and mus-
cle function in elderly women with knee osteoarthritis (OA).
Methods
The study was a double-blinded, placebo-controlled, randomized intervention study that
enrolled individuals with knee pain. Participants were 26 females aged 65–85 years with
knee OA. They performed WBVT and ingested either 16.7 mg of MA or a placebo daily for
20 weeks. We compared the effect of WBVT with placebo (WBVT/P) and WBVT with MA
(WBVT/MA) in participants with various degrees of knee OA (Kellgren and Lawrence (K-L)
grade) using the Japanese Orthopaedic Association (JOA) score and isokinetic dynamome-
ter measurements to evaluate knee and muscle function with two-way ANOVA.
Results
Based on the results of two-way ANOVA analysis of muscle function measurements, there
was significant interaction (time × group) (P = 0.03) in the “isokinetic extension peak torque”
domain for severe OA (K-L grade 3). The simple main effect of time in the WBVT/MA
group (P = 0.04) contributed to this interaction. The JOA score for WBVT/MA supported the
main effect of group as having a significant correlation in the “pain on walking” (P = 0.04)
and “range of motion” (P < 0.01) domains. Participants with severe knee OA in the WBVT/
MA group improved in these domains, whereas the WBVT/P group had few positive results.
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Conclusions
Participants with severe OA who ingested MA in conjunction with WBVT improved their
knee and muscle function. This study suggests that ingesting the anti-inflammatory supple-
ment MA while participating in WBVT, elderly women can reduce knee OA and improve
their knee muscle strength.
Introduction
Knee osteoarthritis (OA) is one of the most common knee joint diseases in the elderly with
25.3 million elderly people affected in Japan alone [1]. Japanese women have traditionally sat
seiza style in which they kneel on their lower legs while resting their buttocks on their heels
[2]. Thus, knee OA in Japanese elderly women may be more severe than in their Western
counterparts. Knee OA involves synovial inflammation and cartilage degradation, and patients
with a severe Kellgren-Lawrence (K-L) grade (K-L 3) have synovitis or joint effusion [3].
Furthermore, severe knee OA can weaken the surrounding muscles [4]. In particular, reduced
quadriceps strength is both a risk factor and a consequence of knee OA [5, 6]. Therefore, many
patients with knee OA have difficulty with their regular routines and daily movements such as
walking or standing, and in severe cases, they require nursing home care.
The Osteoarthritis Research Society International (ORSI) currently recommends a combi-
nation of pharmacological and nonpharmacological treatments as part of nonsurgical manage-
ment for patients with knee OA [7]. However, there is a greater risk of adverse drug events in
elderly people, and they may experience side effects such as gastrointestinal problems, kidney
damage or even kidney failure with the administration of medications such as painkillers and
anti-inflammatory drugs [8]. Consequently, the ideal treatment for elderly patients with knee
OA may be a combination of effective and natural supplements instead of anti-inflammatory
drugs.
Maslinic acid (MA) is a pentacyclic triterpene derived from olives that has produced no
pharmacological problems for elderly people. Its pharmacological functions include anti-
inflammatory, anti-tumor and anti-oxidative properties, among others [9, 10]. Thus, the anti-
inflammatory activity of MA may relieve pain in patients with knee OA.
Resistance exercise is a non-pharmacological treatment that can reduce pain and improve
knee function. Maintaining muscle strength is extremely important for patients with knee OA
[11]. Whole-body vibration training (WBVT), a type of neuromuscular training, is an efficient
resistance exercise method [12]. It has become a popular alternative exercise in hospitals and
fitness clubs because WBVT is typically not burdensome for injured patients or the elderly. In
WBVT, the participant stands on a platform that generates vertical sinusoidal vibrations. Pre-
vious studies have shown that WBVT can improve knee pain, knee function and muscle func-
tion in elderly people with knee OA [13–16].
However, in our examination of the published literature, we found little information on
enhancing the effects of anti-inflammatory agents, such as supplements, with resistance exer-
cise such as WBVT. Therefore, the purpose of this study is to evaluate the efficacy of WBVT in
conjunction with MA supplementation for improving elderly women’s knee and muscle func-
tion. In our double-blind study, we compared parameters of knee OA in patients before and
after they participated in a WBVT program while receiving either MA (WBVT/MA group) or
a placebo (WBVT/P group). We also examined whether the degree of OA affects a patient’s
response to MA during WBVT by comparing the results of participants who had K-L
Maslinic acid ingestion with whole-body vibration training
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grades 2 with those who had K-L grades 3. We investigated whether MA’s anti-inflamma-
tory properties could enhance the effects of WBVT for patients with knee OA.
Materials and methods
This was a double-blinded, placebo-controlled, randomized intervention study in which we
enrolled individuals with knee OA for 20 weeks. A computer randomization list provided by a
research randomizer program (http://www.randomizer.org) assigned participants to either the
WBVT/MA or the WBVT/P group. We gathered all test measurements before and after the
20-week training period.
Participants
The study consisted of a resistance exercise (WBVT) and ingestion of MA or placebo over 20
weeks. We recruited women from nearby residential areas during the two-week period prior
to the study through an advertisement in a local newspaper. We used the following criteria for
selecting study participants from the women who responded: participants must (1) be 65 years
or older, (2) have pain in one or both knees, and (3) not have engaged in organized regular
physical exercise, sports or strength training. Furthermore, we did not include participants
with various health issues such as those with acute disease or severe diabetes, we also excluded
those who were currently engaged in training sessions. We selected 26 of the 97 willing partici-
pants, and their ages ranged from 65–85 years old with a mean of 70.3 years. We informed the
participants not to take any anti-inflammatory or analgesic medications to relieve pain during
the 20-week study. All participants agreed to the study rules.
The Ethics Committee of the University of Tsukuba approved this study (No., Tai 26–24).
All participants provided written informed consent for their participation in the study.
Baseline characteristics
Table 1 shows participants’ baseline characteristics of age, height, weight, body mass index
(BMI), the knee OA grade, duration of knee pain and/or stiffness, existence of any chronic dis-
eases and radiological severity of OA.
Kellgren and Lawrence (K-L) grade
Although a physician did not evaluate participants’ knees for entry into the study, all of them
experienced knee pain. Radiographs for knee joint angles, femorotibial angle, anatomical
Table 1. Participants’ characteristics.
WBVT/MA (n = 11) WBVT/P (n = 15) P-value
Mean ± SD Range Mean ± SD Range
Age years 69.5 ± 2.9 65–73 71.0 ± 5.2 65–85 0.40
Height cm 152.8 ± 4.8 142–159 151.7 ± 5.6 142–159 0.62
Body weight kg 53.4 ± 7.7 38–65 56.0 ± 8.7 43–72 0.43
Body mass index kg/m2 22.8 ± 2.9 17–27 24.4 ± 4.1 18–33 0.29
K-L grade 2 Knees = 15 (63.6%) Knees = 12 (40.0%) 0.14a
K-L grade 3 Knees = 7 (36.4%) Knees = 18 (60.0%)
SD: standard deviation, P-value: Student’s t-test,
a: chi-squared test.
WBVT/MA: whole-body vibration training + maslinic acid capsules, WBVT/P: whole-body vibration training + placebo. K-L: Kellgren and Lawrence.
https://doi.org/10.1371/journal.pone.0194572.t001
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lateral distal femoral angle and anatomical medial proximal tibial angle were measured at Tsu-
kuba Memorial Hospital, Tsukuba, Japan. The radiographs of participants’ knees were
assigned K-L grades (K-L grade 2 or K-L grade 3) in order to rank knee OA severity. Gen-
erally, radiologic knee OA is defined as having at least a K-L grade of 1 or more [17].
Maslinic acid (MA) and placebo
MA (2α, 3β-dihydroxyolean-12-en-28-oic acid) is extracted from the fruit of olives (Fig 1).
The MA product is a non-pharmacological (natural extract) health food that was approved in
Japan prior to our study as a safe to use supplement. Nippon Flour Mills Co, Ltd., Tokyo,
Japan provided the MA and placebo capsules for this double-blind study. The MA capsules
were composed of approximately 10.7% MA, 67% gamma-cyclodextrin, 22.8% protein, 1.5%
fat, 2.5% ash, 3.4% moisture and other minor components. The placebo capsules contained
cornstarch instead of olive fruit extract and were prepared to match the shape and color of the
MA capsules. There were 11 participants in the WBVT/MA group and 15 participants in the
WBVT/P group. The staff checked the records once a month and left comments to motivate
the participants. The participants ingested three capsules of either MA or placebo once daily at
breakfast for 20 weeks.
Whole-body vibration training (WBVT)
We designed the WBVT program mainly to strengthen the hamstrings, calf muscles, quadri-
ceps and surrounding muscles using squats and lunge exercises (Table 2). The program con-
sisted of squats (R1), calves (R2), sit-ups (R3) and up and down (R4). Participants performed
Fig 1. Structure of maslinic acid ((2α,3β)-2,3-Dihydroxyolean-12-en-28-oic acid).
https://doi.org/10.1371/journal.pone.0194572.g001
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all exercises on vertical vibration machines (POWER PLATE pro5, POWER PLATE Interna-
tional, London, UK).
Muscle function evaluation
We used the Biodex isokinetic dynamometer (Biodex Medical Systems, Shirley, NY, USA) to
test the isometric (0 deg/s) knee extension peak torque and isokinetic (60 deg/s) knee exten-
sion/flexion peak torque of both knees in each participant. Participant positioning for the knee
extension and flexion trials has been described previously [18]. Participants performed maxi-
mal isometric knee extensions of 3-s duration at a knee joint angle of 120 deg (180 deg = full
knee extension) [19]. They performed isokinetic knee extension/flexion trials separately three
times with knee joint angle ranging from approximately 90 deg to 80 deg. For each trial, partic-
ipants performed two submaximal and two maximal contractions before testing. They then
performed three maximal voluntary contractions, each one separated by a 5-s pause. A test
period of at least 5 min was allowed between each trial to exclude the effect of fatigue. We used
the Biodex System 4 Advantage software (version 4. 26b) to calculate peak torque and recorded
the highest value from the three trials. Peak torque data were normalized per kilogram of body
weight (Nm/kg).
Knee function evaluation
The Japanese Orthopaedic Association (JOA) score is a scale created by the association in 1998
to measure mobility difficulty in patients with knee OA [20]. It is based on both a subject
Table 2. Characteristics of the whole-body vibration training program.
Week Exercise category Exercise: Muscles targeted Time(s/set) Number of sets
1! 4 Warm-up(6 exercises) Hamstring stretch (W1): Hamstring 30 1 (each leg)
Calf stretch (W2): Calf muscles 30 1 (each leg)
Side stretch (W3): Obliquus externus abdominis 30 1 (each side)
Quadriceps stretch (W4): Quadriceps 30 1 (each leg)
Back relaxer (W5): Latissimus dorsi 30 1
Hip stretch (W6): Gluteus maximus 30 1 (each side)
Resistance training (4 exercises) Squat (R4): Quadriceps, Gluteus maximus, Hamstring 30 1 (1st week)
! 2 (2nd week)
Calves (R4): Calf muscles 30 1! 2
Sit-up (R4): Rectus abdominis 30 1! 2
Up and down (R4): Biceps (Triceps) brachii, Trapezius, Quadriceps 30 1 (each leg)
! 2
Cool-down (3 exercises) Calf massage (C4): Calf muscles 60 1
Hamstring massage (C4): Hamstring 60 1
Quadriceps massage (C4): Quadriceps 60 1
Back massage (C4): Latissimus dorsi 60 1
5! 10 Warm-up (The same 6 exercises as 1st through 4th weeks)
Resistance training (5 exercises) (The same 4 exercises as the 4th week): Quadriceps
+ Pelvic bridge (R5): Gluteus maximus, Hamstring
30 1 (3rd week)
! 2 (5th week)
Cool-down (The same 4 exercises as 1st through 4th weeks)
11! 20 Warm-up (The same 6 exercises as 1st through 4th weeks)
Resistance training (6 exercises) (The same 5 exercises as the 5th week): Quadriceps
+ Front lunge (R6): Gluteus maximus
30 1 (each leg)
(11th week)
! 2 (13th week)
Cool-down (The same 4 exercises as 1st through 4th weeks)
https://doi.org/10.1371/journal.pone.0194572.t002
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interview and the diagnosis of an orthopedist. In the present study, we acquired JOA score
measurements on both knees of the participants. Participants graded their subjective condition
on a scale of 0–100 with 100 indicating “very good” in the following four areas: pain on walk-
ing, pain on ascending or descending stairs, range of motion and joint effusion. This grading
system numerically evaluated difficulties in walking and climbing stairs, mobility level and
joint swelling.
Statistical analysis
We compared baseline characteristics as mean with standard error or as frequency between
groups using non-paired t-test or chi-squared test, respectively. Two-way analysis of variance
(ANOVA), was used to determine whether differences existed between values (two levels for
the time factor: pre- and post-trial) for each group (group factor: WBVT/MA and WBVT/P)
according to all outcome measures. When an interaction was significant, we examined the
simple effect of time and group. In addition, when interaction was not significant, we tested
the main effect of time and group. We calculated 95% confidence intervals for all outcome
measures pre- and post-trial. The effect sizes (Cohen’s d) between pre- and post-trial data were
determined by using the average change and excluding the pre-test standard deviation. The
calculated intraclass correlation coefficient (ICC) based on pre- and post-trial data was moder-
ate or greater (0.41~0.87). The calculated coefficient of variation based on pre-test data was
0.11 to 0.36. Effect size (d) standards were 0.2 = small, 0.5 = moderate and 0.8 = large. IBM
SPSS Statistics 22 software for Windows (IBM, Armonk, NY) performed all statistical process-
ing. Statistical significance was set at P< 0.05.
Results
Baseline characteristics and the trial of MA and placebo
The 26 participants’ ages ranged from 65–85 years with a mean of 70.3 years, and their mean
body mass index (BMI) was 23.7 kg/m2 with a range of 16.5–32.7 kg/m2 (Table 1). The Japa-
nese Ministry of Health, Labour and Welfare (2013) lists the average BMI at 22.6 kg/m2
between 60–69 years and 23.0 kg/m2 at 70 years and older. Therefore, participants’ BMIs are
typical of this Japanese age population.
We determined the Kellgren and Lawrence (K-L) grade for both knees of the participants
through radiographs. From these results, we found that 51.9% (27 knees) of participants had
K-L grade 2 and 48.1% (25 knees) had K-L grade 3. Participants’ reported two patterns of
knee pain. One in which the participants were having knee pain on both sides of a knee, one in
which the knee pain was only on one side of the knee. The number of knees with pain that had
a K-L grade 2 in the WBVT/MA group was 15 and in the WBVT/P group it was 12. The
number of knees with pain that had a K-L grade 3 in the WBVT/MA group was 7 and in
the WBVT/P group it was 18. There were no significant differences (P< 0.05) between the
WBVT/MA and WBVT/P groups. All participants were diagnosed with knee OA. Participants
consumed either three 50 mg MA capsules (16.7 mg of MA) or three placebo capsules at break-
fast, depending on their assigned group. This continued over the 20-week program. Therefore,
the participants in the WBVT/MA group consumed 2338 mg over the entire trial period of 20
weeks.
Performance of WBVT program
Table 2 shows the progression of exercises in the WBVT program for this study. We calculated
the training session attendance rates for each group. There were 440 participant-training
Maslinic acid ingestion with whole-body vibration training
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hours available for the WBVT/MA group (11 participants × 40 sessions) and 600 participant-
training hours available for the WBVT/P group (15 participants × 40 sessions). Members of
the WBVT/MA group attended 422 hours, which was a 95.9% attendance rate, and members
of the WBVT/P group attended 581 hours for a 96.8% attendance rate.
Depending on the results of participants’ first four weeks in the program, we added other
exercises to strengthen knee muscles, such as the pelvic bridge (R5), during weeks five to ten.
If the participants progressed sufficiently during the first ten weeks of the program, we chal-
lenged them during the last ten weeks of the program with more difficult strengthening exer-
cises such as the front lunge (R6). Although all participants entered the WBVT program with
knee pain, they all successfully progressed through our entire WBVT program.
Muscle function
Table 3 indicates the pre- and post-trial muscle function measurement outcomes and results
of the two-way ANOVA. There was significant time × group interaction in the “isokinetic
extension peak torque” domain (P = 0.03) for participants with K-L 3. The simple main
Table 3. Muscle function by group at baseline and follow-up.
Week Mean SD 95% CI Effect size
Cohen’s d
Mean SD 95% CI Effect size
Cohen’s d
Interaction Main effect Simple main
effect (time)
Kellgren & Lawrence
Grade 2
WBVT/MA (knees = 15) WBVT/P (knees = 12)
Isometric extension peak
torque, Nm/kg
0 1.68 ± 0.25 (1.53–
1.83)
0.92 1.54 ± 0.47 (1.24–
1.84)
0.38 0.62 Time
P< 0.01
21 1.95 ± 0.33 (1.75–
2.15)
1.73 ± 0.52 (1.40–
2.08)
Group
P = 0.22
Isokinetic extension peak
torque, Nm/kg
0 1.17 ± 0.33 (0.97–
1.37)
0.37 1.06 ± 0.42 (0.79–
1.33)
0.52 0.70 Time
P< 0.01
21 1.31 ± 0.42 (1.06–
1.57)
1.25 ± 0.30 (1.06–
1.44)
Group
P = 0.53
Isokinetic flexion peak
torque, Nm/kg
0 0.79 ± 0.20 (0.67–
0.91)
0.90 0.78 ± 0.18 (0.66–
0.90)
0.66 0.77 Time
P = 0.01
21 0.97 ± 0.18 (0.86–
1.08)
1.00 ± 0.44 (0.72–
1.28)
Group
P = 0.91
Kellgren & Lawrence
Grade 3
WBVT/MA (knees = 7) WBVT/MA (knees = 18)
Isometric extension peak
torque, Nm/kg
0 1.42 ± 0.35 (1.15–
1.69)
0.43 1.19 ± 0.28 (1.06–
1.33)
-0.04 0.10 Time
P = 0.15
21 1.58 ± 0.40 (1.28–
1.89)
1.18 ± 0.30 (1.03–
1.33)
Group
P< 0.01
Isokinetic extension peak
torque, Nm/kg
0 0.82 ± 0.33 (0.56–
1.07)
0.59 0.90 ± 0.32 (0.74–
1.05)
-0.24 0.03 WBVT/MA
P = 0.04
21 1.01 ± 0.31 (0.82–
1.29)
0.84 ± 0.18 (0.75–
0.92)
WBVT/P P = 0.43
Isokinetic flexion peak
torque, Nm/kg
0 0.64 ± 0.13 (0.54–
0.74)
0.98 0.71 ± 0.28 (0.57–
0.85)
0.44 0.59 Time
P = 0.04
21 0.80 ± 0.19 (0.65–
0.95)
0.81 ± 0.15 (0.73–
0.88)
Group
P = 0.53
Cohen’s d: |0.2 d< 0.5| = small, |0.5  d< 0.8| = moderate, |0.8 d| = large.
P< 0.05, CI: confidence interval.
WBVT/MA: whole-body vibration training + maslinic acid capsules, WBVT/P: whole-body vibration training + placebo.
https://doi.org/10.1371/journal.pone.0194572.t003
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effect of time in the WBVT/MA group contributed to this result (P = 0.04). In contrast, the
other domains showed no significant time × group interactions.
For the main effect of time, there were significant results in all domains for participants
with K-L 2 (P< 0.01 or P = 0.01) and in the “isokinetic flexion peak torque” for participants
with K-L 3 (P = 0.04). The “isometric extension peak torque” for participants with K-L 3
had a significant result only in the main effect for that group (P< 0.01).
For knee strength in the WBVT/P group, participants with K-L 2 knees had small or
moderate effect sizes (d = 0.38–0.66) for all domains, and for K-L 3 knees, the effect size for
the “isokinetic flexion peak torque” was small (d = 0.44). Furthermore, the effect size for the
“isokinetic and isometric extension peak torque” indicated a worsening knee for the WBVT/P
participants with K-L 3 (d = -0.24 –-0.04).
On the other hand, the effect sizes of all domains in the WBVT/MA group were higher than
the effect sizes in the WBVT/P group. In particular, “isometric extension peak torque”
(d = 0.92) and “isokinetic flexion peak torque” (d = 0.90) for participants with K-L 2, and
“isokinetic flexion peak torque” (d = 0.98) for those with K-L 3 were remarkably higher in
the WBVT/MA group than in the WBVT/P group.
Knee function
Table 4 shows the pre- and post-trial means and 95% confidence intervals for knee function
measurements and results of the two-way ANOVA. There was no significant time × group
interaction in knee function (P = 0.24–0.84). However, we found a significant main effect of
time in “pain on ascending or descending stairs” for participants with K-L 2 (P< 0.01). In
the K-L 3 group, the main effect of group in the “pain on walking” (P = 0.04) and “range of
motion” (P< 0.01) domains was significant.
The effect size (Cohen’s d) of “pain on ascending or descending stairs” for participants
with K-L 2 was large only in the WBVT/P group (d = 1.13). Whereas in the WBVT/MA
group, participants with K-L 2 had a moderate effect size for “pain on ascending or
descending stairs” (d = 0.62), and participants with K-L 3 had moderate effect sizes for
“range of motion” (d = 0.71) and “joint effusion” (d = 0.50). Furthermore, the effect sizes for
“pain on walking” and “pain on ascending or descending stairs” of participants in the
WBVT/P group with a K-L 3 score indicated worsening knee pain (d = -0.57, -0.22,
respectively).
Discussion
We designed this study for elderly women to participate in a resistance exercise program, such
as WBVT, over 20 weeks while receiving either a MA supplement (WBVT/MA group) or a
placebo (WBVT/P group). Since knee pain can worsen during cold weather, all participants
started and completed the WBVT exercise program prior to the cold winter weather. Unfortu-
nately, we only had five WBV units available for our study allowing us to include a relatively
small number of participants, which was a limitation of our study.
All participants (elderly women ranging from 65–85 years) identified themselves as having
knee OA: 51.9% (knees = 27) had K-L grades 2 and 48.1% (knees = 25) had K-L 3
(Table 1). According to D’Agostino et al. [3], participants with knee OA and a K-L grade 3
have synovitis or joint effusion on clinical examination and present with knee joint swelling.
Their results showed a high correlation between the radiographic stage of knee OA and the
inflammatory process. The inflammation correlated statistically with advanced radiographic
disease (K-L grade 3 for synovitis and joint effusion). Indeed, participants with a K-L
grade 3 in this study also had synovitis or joint effusion and inflammation in their knees.
Maslinic acid ingestion with whole-body vibration training
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Maslinic acid derived from olives has been garnering attention as a dietary supplement in
Japan; it reduces inflammation and swelling [21, 22]. Fukumitsu et al. [23] reported that MA
can suppress mild knee pain and improve quality of life (QoL) by promoting weight loss in the
elderly. MA affects the production of tumor necrosis factor-a (TNF-a), a type of cytokine
which causes rheumatism [10]. Even though MA is considered a natural and safe supplement,
it can potentially reduce inflammation in patients with knee OA similar to an anti-inflamma-
tory drug. To study MA’s ability to relieve knee arthritis in elderly women, we conducted a
study with participants that had knee OA. To reduce inflammation in the osteoarthritic knees,
we incorporated treatment with MA, which has no pharmacological side effects, with resis-
tance exercise (WBVT) to improve muscle strength over a 20-week period. Our two-way
ANOVA analysis of the muscle function measurements provided a quantitative evaluation of
participants’ knee joints and knee muscles (Table 3).
Table 4. Japanese Orthopaedic Association score by group at baseline and follow-up.
Week Mean
SD
95% CI Effect size
Cohen’s d
Mean
SD
95% CI Effect size
Cohen’s d
Interaction Main effect
Kellgren & Lawrence Grade 2 WBVT/MA (knees = 15) WBVT/P (knees = 12)
Pain on walking, score 0 28.8 ± 2.2 (27.5–
30.2)
0.43 29.6 ± 1.4 (28.7–30.5) 0.41 0.61 Time P = 0.09
21 29.6 ± 1.4 (28.8–
29.9)
30.0 ± 0.0 – Group
P = 0.27
Pain on ascending or descending
stairs, score
0 21.2 ± 4.2 (18.4–
23.7)
0.62 20.8 ± 1.9 (19.6–22.1) 1.13 0.84 Time
P < 0.01
21 23.5 ± 3.2 (21.6–
25.4)
23.3 ± 2.5 (21.8–24.9) Group
P = 0.84
Range of motion, score 0 31.9 ± 4.8 (29.0–
34.8)
0.21 33.3 ± 2.5 (31.8–34.9) 0.18 0.75 Time P = 0.28
21 32.7 ± 2.6 (31.1–
34.3)
33.8 ± 2.3 (32.3–35.2) Group
P = 0.31
Joint effusion, score 0 9.6 ± 1.4 (8.8–10.5) – 10.0 ± 0.0 – – – –
21 9.6 ± 1.4 (8.8–10.5) 10.0 ± 0.0 – –
Kellgren & Lawrence Grade 3 WBVT/MA (knees = 7) WBVT/P (knees = 18)
Pain on walking, score 0 28.3 ± 2.5 (26.4–
30.3)
– 26.9 ± 4.2 (24.8–29.1) -0.57 0.26 Time P = 0.28
21 28.3 ± 2.5 (26.4–
30.3)
24.2 ± 5.5 (21.4–26.9) Group
P = 0.04
Pain on ascending or descending
stairs, score
0 16.7 ± 7.9 (10.6–
22.7)
0.39 16.7 ± 6.4 (13.5–19.9) -0.22 0.24 Time P = 0.69
21 19.4 ± 5.8 (15.0–
23.9)
15.3 ± 6.5 (12.03–
18.5)
Group
P = 0.33
Range of motion, score 0 32.2 ± 2.6 (30.2–
34.2)
0.71 28.1 ± 4.6 (25.8–30.3) 0.12 0.39 Time P = 0.09
21 33.9 ± 2.2 (32.2–
35.6)
28.6 ± 4.8 (26.2–31.0) Group
P < 0.01
Joint effusion, score 0 9.4 ± 1.7 (8.2–10.7) 0.50 8.6 ± 2.3 (7.5–9.8) 0.10 0.47 Time P = 0.81
21 10.0 ± 0.0 – 8.3 ± 3.4 (6.6–10.0) Group
P = 0.15
Cohen’s d: |0.2 d< 0.5| = small, |0.5  d< 0.8| = moderate, |0.8 d| = large.
P< 0.05, CI: confidence interval.
WBVT/MA: whole-body vibration training + maslinic acid capsules, WBVT/P: whole-body vibration training + placebo.
https://doi.org/10.1371/journal.pone.0194572.t004
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In particular, “isokinetic extension peak torque” had a significant time × group interaction
in participants with knees graded at K-L 3. This indicates that the effectiveness of WBVT
with MA supplementation (WBVT/MA group) depends on the time parameter. The detailed
findings support the significance of the simple main effect of time for participants with
K-L 3 (P = 0.04). From these results, we found that WBVT led to improved muscle strength
and that MA is more effective when the K-L grade is severe (K-L 3) as opposed to mild or
moderate (K-L 2). Thus, it is clear from our results that the elderly participants with more
serious knee OA who received MA during the 20-week exercise program (WBVT/MA)
received considerable benefit from this combination.
The effect size (d) results also revealed that participants in the WBVT/MA group had better
muscle function than those in the WBVT/P group in all domains. MA seemed to improve
muscle strength as seen with isokinetic knee extension/flexion peak torque measurements.
From these results, we found that WBVT led to improved muscle strength and that MA is
more effective when the K-L grade is severe (K-L 3) as opposed to mild or moderate
(K-L 2). This is supported by MA’s pharmacological function as an anti-inflammatory
agent. Synovitis and effusion are common in painful knee OA, and the presence of synovitis
and effusion are strongly related to medial hamstring function. Rutherford et al. [24] and
Torry et al. [25] reported that vastus medialis and vastus lateralis activity decreased, on aver-
age, 8.5% and 50%, respectively. In general, hamstring function is related to a loss of knee
extension strength [26, 27]. Furthermore, Lewek et al. [28] observed poor knee extension
strength in participants with knee OA. There must be a critical interaction between dynamic
and passive muscle forces to stabilize the knee joint during walking, running, jumping and the
like. This is a possible explanation for the strong relationship between knee joint effusion and
hamstring muscle strength.
Specifically, our WBVT program consists of hamstring stretch (W1), squat (R1), ham-
string massage (C2) and pelvic bridge (R5) (Table 2) because these exercises correlate to
strengthening of the hamstring muscles. Tillaar [26] also reported that WBVT, in particular,
may improve flexibility of the hamstrings. In addition, Mathers et al. [27] reported that the
inflammatory responses to exercise-induced muscle damage influence subsequent muscle
regeneration.
The JOA scores (two-way ANOVA) showed that there was no significant time × group
interaction for knee function (Table 4). However, as an individual main effect, time had a sig-
nificant correlation (P< 0.01) with “pain on ascending or descending stairs” for participants
with K-L 2. This makes sense since participants with mild knee OA increased muscle mass
around their knees during the 20-week WBVT program, making it easier to ascend and
descend stairs without knee pain. Furthermore, the participants with K-L grade 2 had no
synovitis or joint effusion, so their knee pain was unrelated to knee inflammation.
WBVT was a useful resistance training exercise for all study participants with mild knee
OA (K-L 2) regardless of the supplementation; the exercise helped them build leg muscles
and improved their ability to ascend and descend stairs. This result is consistent with previous
studies of WBVT [13–16]. We demonstrated that WBVT can improve knee pain in elderly
people with knee OA and improve knee function in joints with mild OA.
On the other hand, for participants with severe OA (K-L 3), the main effect of group cor-
related significantly with “pain on walking” (P = 0.04) and “range of motion” (P< 0.01). The
WBVT/MA group improved in these domains, but the WBVT/P group did not. Although
“pain on walking” did not improve in the WBVT/MA group (mean 28.3 pre-trial to 28.3 post-
trial), it actually worsened in the WBVT/P group (mean 26.9 to 24.2). In addition, “pain on
ascending or descending stairs” (mean 16.7 to 15.3) also worsened in the WBVT/P group. It
appears that a resistance exercise such as WBVT, without the addition of an anti-inflammatory
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such as MA, is burdensome for knees with severe K-L grades (K-L 3). Resistance exercise
can cause excessive strain on osteoarthritic knees which may lead to further injury or damage
[29].
MA functions as an anti-inflammatory and anti-arthritic agent, which is demonstrated by
the suppression of carrageenan-induced paw edema, inflammatory cells and destruction of
synovium in knee joints [30]. Fukumitsu et al. [31] performed a comparison study of serum
hs-CRP between MA and placebo over a 12-week treatment period. The MA intake group had
a higher serum hs-CRP level than the placebo group. The authors found that MA improved
joint condition and QoL by reducing pain and the inflammatory response. Our results also
showed that MA is an effective supplement for participants with severe knee OA (K-L 3).
Decreased knee inflammation alleviated knee pain in participants with severe OA (K-L 3) in
the WBVT/MA group. If MA did not relieve knee inflammation, the knee pain in participants
with severe OA would not have improved because it is the severe inflammation that causes the
swelling, pain and restricted range of motion in the joint. It is clear that MA intake was effec-
tive in relieving knee inflammation for participants with synovitis or joint effusion (K-L 3).
Furthermore, with the gradual reduction in knee inflammation, participants in the WBVT/
MA group with K-L grades 3 could bend their knees with less pain and improved range of
motion. They could then fully engage their leg muscles during the WBVT program and build
more muscle mass. The “range of motion” domain is directly related to bending the knees.
Although, the widely used WOMAC (Western Ontario and McMaster Universities Osteo-
arthritis Index) [32] is just a questionnaire for participants, JOA score parameters are based on
an orthopedist’s interview and diagnosis. The “pain on ascending or descending stairs” and
“pain on walking” scores come from interviews, but “range of motion” and “joint effusion” are
obtained through clinical assessment. Thus, the JOA score is a quantitative evaluation of physi-
cal impairment and disability in patients with knee OA [33]. The JOA “range of motion”
domain asks a subject about the “flexion or arc of motion” at angles ranging from 110˚ to 35˚.
These angles include the positioning of seiza-style sitting and also evaluates knee pain. For our
study, we adopted the JOA score to evaluate the efficacy of WBVT and MA supplementation
Fig 2. Mean value of the difference between post- and pre-trial for each group (group factor: WBVT/MA and WBVT/P). (A) Muscle function and (B) Knee
function. The bars represent upper and lower 95% confidence interval value.
https://doi.org/10.1371/journal.pone.0194572.g002
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on elderly women’s knee function. Our results indicated that “pain on walking” and “range of
motion” were strongly related to “isokinetic extension peak torque” measurements of the mus-
cle function results. Fig 2 is a visual representation showing the differences in muscle and knee
function between the WBVT/MA and WBVT/P groups. This study suggests that, to reduce
knee OA in elderly women, the use of MA as an inflammatory drug can be an effective treat-
ment to improve knee muscle strength when used with resistance exercises such as WBVT.
The results do not prove the effect of MA alone in reducing the inflammation since there
were a limited number of participants in this study. Therefore, we cannot generalize these find-
ings as a curative and rehabilitative treatment based on this study alone. Furthermore, the
potential for response bias as to the efficacy of WBVT/MA must be taken into consideration
and tested through the measurement of inflammatory biomarkers such as cytokines.
Conclusion
An ideal treatment for elderly women with knee OA is a combination of an effective anti-
inflammatory supplement, rather than a drug, to reduce knee pain and a low-burden resis-
tance exercise to improve knee muscle strength. Participants in the WBVT/MA group with
severe OA (K-L 3) and synovitis or joint effusion showed remarkable improvement in knee
and muscle function during their 20-week training period. This study suggests that to reduce
knee pain in elderly women, the anti-inflammatory supplement MA is an effective treatment
when used in combination with WBVT for improving knee muscle strength.
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